broad
spectrum
detect
platform
provid
sequenc
level
resolut
target
region
would
signific
impact
public
health
case
manag
mean
expand
understand
etiolog
diseas
previous
develop
respiratori
pathogen
microarray
rpm
demonstr
capabl
platform
purpos
newli
develop
rpm
use
analyz
wellcharacter
nasal
wash
specimen
patient
present
febril
respiratori
ill
washington
c
metropolitan
region
specimen
rpm
result
compar
composit
refer
assay
viral
bacteri
cultur
appropri
rtpcrpcr
result
across
panel
rpm
assay
show
overal
agreement
organ
detect
compar
refer
method
addit
rpm
result
provid
sequenc
inform
allow
phylogenet
classif
circul
influenza
virus
clinic
specimen
allow
monitor
genet
variat
well
antigen
variabl
predict
multipl
pathogen
detect
specimen
notabl
increas
abund
respiratori
colon
esp
pneumonia
viral
infect
firstev
comparison
broadspectrum
viral
bacteri
identif
technolog
type
larg
batteri
convent
gold
standard
assay
confirm
util
approach
medic
surveil
investig
complex
etiolog
ill
caus
respiratori
coinfect
emerg
infect
nonspecif
symptom
enorm
impact
public
health
global
econom
eg
sever
acut
respiratori
syndrom
outbreak
avian
influenza
outbreak
emphas
need
effici
simultan
detect
multipl
organ
facilit
time
judici
implement
countermeasur
outbreak
contain
treatment
intervent
case
manag
ideal
system
capabl
detect
potenti
relev
organ
need
mani
technolog
develop
view
toward
address
issu
exampl
masscodetm
multiplex
rtpcr
system
electrospray
ioniz
mass
spectrometri
analysi
pcr
amplicon
luminexh
xmap
tm
microarray
base
approach
promis
technolog
test
detect
pathogen
particular
class
pathogen
simultan
addit
technolog
provid
limit
rang
genet
resolut
requir
addit
test
determin
detail
mutat
strainvari
detect
pathogen
high
densiti
resequenc
array
provid
resolut
individu
nucleotid
long
target
sequenc
hundr
thousand
nucleotid
demonstr
discrimin
mutat
target
pathogen
well
sensit
specif
similar
improv
technolog
base
subset
organ
microarray
design
detect
respiratori
pathogen
microarray
version
rpm
provid
comprehens
coverag
potenti
caus
respiratori
ill
target
much
broader
rang
organ
includ
bacteria
dna
rna
virus
singl
test
potenti
method
previou
work
rpm
demonstr
detect
pathogen
individu
genom
copi
use
spike
sampl
well
select
organ
clinic
sampl
also
demonstr
use
cultur
isol
clinic
sampl
detail
analysi
strain
distribut
influenza
virus
possibl
unfortun
directli
use
clinic
sampl
success
attribut
flu
sampl
correct
flu
season
accomplish
accuraci
base
call
array
compar
de
novo
sequenc
use
cultur
isol
clinic
sampl
studi
demonstr
one
challeng
develop
multiplex
detect
system
broad
rang
differ
organ
valid
test
result
sampl
avail
subject
test
larg
number
divers
pathogen
similarli
archiv
clinic
specimen
use
previou
studi
origin
test
select
target
multipl
organ
detect
rpm
alway
possibl
perform
confirmatori
test
due
lack
avail
materi
limit
use
archiv
sampl
valid
newli
develop
multiplex
assay
timeconsum
costli
thu
make
multipl
confirmatori
assay
clinic
specimen
difficult
achiev
studi
valid
potenti
respiratori
pathogen
microarray
rpm
provid
broadspectrum
pathogen
detect
set
clinic
sampl
collect
washington
dc
metropolitan
region
decemb
februari
subject
full
panel
convent
microbi
analysi
cultur
andor
rtpcrpcr
well
analysi
rpm
microarray
set
sampl
demonstr
good
agreement
across
panel
test
make
authent
multipl
detect
event
rpm
microarray
possibl
mani
specimen
set
repres
coinfect
provid
rang
multitarget
sampl
analysi
use
clinic
sampl
rather
cultur
isol
demonstr
detail
analysi
strain
distribut
influenza
virus
within
flu
season
well
provid
phylogenet
measur
circul
influenza
strain
accuraci
base
call
confirm
comparison
de
novo
sequenc
use
repres
clinic
sampl
comparison
broadspectrum
viral
bacteri
identif
technolog
larg
batteri
convent
gold
standard
assay
repres
rigor
test
approach
medic
surveil
investig
complex
etiolog
carri
previous
studi
provid
previous
unavail
fundament
assess
multipl
pathogen
detect
assay
pave
way
improv
microarraybas
platform
would
provid
comprehens
multipl
pathogen
detect
singl
test
implic
limit
assay
also
discuss
specimen
collect
six
militari
treatment
facil
washington
dc
metropolitan
region
decemb
februari
demograph
washington
dc
metropolitan
region
previous
shown
broad
age
gender
geograph
distribut
patient
recruit
emerg
depart
clinic
set
natur
possibl
consequ
studi
explain
inform
consent
obtain
particip
patient
sampl
store
cvm
media
hardi
diagnost
santa
maria
ca
viral
cultur
process
store
tryptic
soy
broth
glycerol
bacteri
analysi
ship
frozen
destin
laboratori
analysi
sampl
collect
research
conduct
complianc
applic
feder
intern
regul
govern
protect
human
subject
research
naval
medic
center
protocol
rpm
design
specimen
process
protocol
microarray
analysi
describ
detail
previou
public
microarray
hybrid
process
carri
accord
manufactur
recommend
protocol
affymetrix
inc
santa
clara
ca
follow
modif
purifi
pcr
product
fragment
minut
label
minut
hybrid
carri
hybrid
oven
revmin
hour
imag
scan
process
produc
fasta
output
file
perform
previous
describ
final
pathogen
identif
rpm
assay
perform
use
computerimpl
biolog
sequenc
identifi
cibsi
version
softwar
automat
pathogen
identif
algorithm
base
nucleic
acid
sequenc
develop
test
detail
previou
studi
independ
assay
perform
use
bacteri
viral
cultur
except
difficulttocultur
pathogen
pcr
method
use
addit
assay
primarili
convent
andor
realtim
pcr
rtpcr
perform
cultur
neg
sampl
test
pathogen
occur
titer
low
cultur
andor
loss
viabil
transport
overal
specimen
defin
posit
pathogen
composit
assay
result
cultur
andor
duplic
pcr
assay
posit
viral
analys
perform
focu
diagnost
inc
capcertifi
refer
laboratori
cypress
ca
air
forc
institut
oper
health
brook
citi
base
tx
viral
process
includ
inocul
sampl
monitor
cytopath
effect
day
monitor
subpassag
necessari
confirmatori
test
need
ie
direct
monoclon
immunofluoresc
assay
indirect
immunofluoresc
assay
pcr
bacteri
analys
perform
naval
health
research
center
nhrc
san
diego
ca
respiratori
diseas
laboratori
sampl
analyz
presenc
bacteri
pathogen
util
classic
cultur
techniqu
select
agar
plate
cultur
method
growth
resembl
coloni
appropri
target
pathogen
confirmatori
test
eg
suscept
disk
biochem
test
conduct
verifi
ident
suspect
coloni
initi
pcr
analys
difficulttocultur
pathogen
bordetella
pertussi
chlamydia
pneumoniaepsittaci
coronaviru
mycoplasma
pneumonia
perform
nhrc
respiratori
diseas
laboratori
focu
diagnost
inc
cypress
ca
speciesspecif
rtpcr
amplif
assay
perform
cultureneg
rpm
sampl
posit
cultureposit
rpm
neg
cultureneg
rpm
control
assay
perform
nrl
use
previous
publish
primer
tabl
gener
ml
pcr
reaction
run
myiq
tm
realtim
pcr
detect
system
biorad
hercul
ca
usa
convent
pcr
assay
analyz
electrophoresi
tae
agaros
gel
sequenc
reaction
perform
sequetech
mountain
view
ca
sequenc
align
influenzaposit
sampl
perform
hemagglutinin
sequenc
use
magalign
function
lasergen
version
dnastar
inc
madison
wi
root
phylogenet
tree
gener
use
neighborjoin
method
paup
sinauer
associ
inc
publish
sunderland
root
reliabl
estim
assess
use
bootstrap
replic
total
sampl
test
use
rpm
assay
parallel
refer
assay
cultur
andor
pcr
test
sensit
specif
rpm
assay
determin
use
variou
prototyp
strain
clinic
sampl
previou
studi
studi
influenza
viru
commonli
identifi
respiratori
pathogen
method
respect
refer
assay
rpm
method
show
detect
sensit
specif
overal
agreement
tabl
influenza
viru
influenza
b
rpm
detect
sensit
specif
overal
agreement
tabl
three
influenza
cultureposit
specimen
also
posit
microarray
howev
two
specimen
identifi
influenza
aposit
cultur
clearli
detect
influenza
b
microarray
realtim
rtpcr
later
concur
microarray
result
cultur
specimen
inde
influenza
bposit
rpm
also
demonstr
excel
detect
sensit
specif
overal
agreement
respect
refer
assay
result
pathogen
detect
tabl
capabl
rpm
system
identif
complex
mixtur
pathogen
demonstr
assess
incid
coinfect
sampl
sampl
show
viral
viral
bacteri
coinfect
determin
rpm
andor
cultur
tabl
coinfect
verifi
use
publish
typespecif
pcr
assay
inhous
specif
pcr
primer
tabl
well
known
pneumonia
n
meningitidi
colon
mouth
upper
respiratori
system
surpris
common
coinfect
found
clinic
sampl
howev
consist
previou
studi
quantit
realtim
pcr
data
show
pneumonia
present
influenzaposit
sampl
harbor
high
titer
genom
copiesml
compar
influenzaneg
sampl
data
shown
high
titer
bacteria
present
clinic
sampl
possibl
viral
induc
bacteri
superinfect
first
suggest
find
madhi
et
al
peltola
mcculler
critic
aspect
influenza
epidemiolog
track
genet
chang
within
influenza
strain
sinc
antigen
drift
mechan
influenza
virus
escap
immunolog
pressur
induc
previou
natur
exposur
vaccin
analysi
key
amino
acid
deduc
nucleotid
sequenc
sequenc
influenza
posit
isol
reveal
two
major
circul
strain
anew
group
group
ii
tabl
group
belong
lineag
carri
signatur
amino
acid
substitut
antigen
site
valin
isoleucin
posit
serin
prolin
posit
group
ii
show
lineag
signatur
amino
acid
substitut
posit
serin
asparagin
posit
key
amino
acid
antigen
site
b
surprisingli
outlier
sampl
identifi
like
isol
amino
acid
posit
correspond
correspond
correspond
tile
prototyp
sequenc
tabl
use
repres
sampl
phylogenet
analysi
comparison
sequenc
gener
rpm
resolv
base
fig
sequenc
gener
via
convent
sequenc
resolv
base
fig
show
similar
result
indic
ambigu
base
call
microarray
affect
phylogeni
determin
influenza
virus
tabl
fig
repres
sampl
wyom
despit
effort
establish
complet
blind
independ
test
everi
pathogen
viral
bacteri
cultur
appropri
rtpcrpcr
differ
detect
sensit
method
transport
issu
necessit
use
confirmatori
test
measur
uncertainti
introduc
qualiti
refer
assay
servic
local
refer
laboratori
could
arrang
sampl
transport
san
diego
ca
furthermor
although
larg
sampl
volum
set
asid
refer
assay
reduct
detect
sensit
still
inevit
sampl
split
frozen
test
viral
bacteri
agent
separ
cultur
reduc
uncertainti
archiv
sampl
store
time
origin
test
retest
use
realtim
rtpcrpcr
hous
addit
refer
method
rpmposit
cultureneg
sampl
use
posit
posit
rpm
cultur
neg
control
neg
rpm
cultur
combin
result
confirmatori
test
demonstr
excel
concord
rpm
tabl
tabl
overal
agreement
organ
detect
fals
positiveneg
rate
within
reason
rang
expect
test
two
method
seen
pcr
assay
method
compar
cultur
method
two
organ
detect
sensit
coronavirus
pneumonia
rpm
lower
compar
pcr
method
indic
need
improv
andor
optim
primer
set
use
rpm
assay
organ
howev
specif
remain
high
organ
abil
test
multipl
pathogen
increasingli
recogn
necess
especi
case
differenti
diagnosi
etiolog
agent
difficult
broadspectrum
diagnost
particularli
use
differ
etiolog
agent
caus
similar
symptom
respiratori
ill
cocircul
popul
coinfect
multipl
organ
potenti
import
epidemiolog
symptomolog
treatment
howev
difficult
cumbersom
costli
detect
multipl
pathogen
coinfect
use
cultur
method
singl
test
pcr
method
current
report
coinfect
rate
among
respiratori
pathogen
vari
due
differ
breadth
sensit
detect
method
use
rpm
confirm
realtim
rtpcrpcr
studi
found
test
sampl
show
viral
viralbacteri
coinfect
tabl
challeng
increas
difficulti
organ
cover
establish
valid
broad
spectrum
platform
gold
standard
exist
archiv
sampl
test
larg
number
organ
addit
pathogen
detect
sequenc
obtain
use
rpm
provid
use
addit
inform
track
strain
variat
without
addit
test
studi
show
major
clinic
sampl
test
posit
influenza
b
viru
surpris
sampl
collect
result
confirm
rpm
use
tool
influenza
surveil
also
predict
antigen
variat
benefici
vaccin
candid
predic
consid
result
high
level
confid
gener
reliabl
resequenc
approach
simultan
pathogen
detect
strainvari
identif
directli
clinic
sampl
establish
result
show
excel
correl
refer
assay
neither
rpm
test
conduct
refer
assay
repres
complet
coverag
respiratori
pathogen
consequ
pathogen
detect
specimen
patient
still
exhibit
flulik
symptom
furthermor
rpm
design
proofofconcept
microarray
detect
common
respiratori
pathogen
encount
among
militari
basic
traine
larg
section
chip
dedic
adenovirus
influenza
virus
work
use
survey
slightli
differ
popul
within
washington
dc
metropolitan
region
broad
age
gender
geograph
distribut
may
differ
mix
common
pathogen
addit
major
caus
common
cold
rhinovirus
enterovirus
repres
rpm
subsequ
strain
recogn
strain
rhinoviru
none
enterovirus
detect
rpm
confirmatori
assay
identifi
sever
organ
ie
h
influenza
clinic
specimen
rpm
design
detect
addit
preliminari
test
new
chip
design
thorough
coverag
pathogen
identifi
pathogen
confirmatori
assay
detect
rpm
detect
unpublish
data
indic
potenti
technolog
reduc
number
sampl
attribut
test
organ
significantli
smaller
number
current
possibl
major
difficulti
current
technolog
associ
primer
select
amplif
chosen
target
design
multiplex
amplif
strategi
time
consum
effort
current
system
remain
somewhat
vulner
rapid
mutat
rna
virus
new
resequenc
array
design
increas
number
pathogen
would
requir
recalibr
multiplex
primer
mix
one
solut
alreadi
mitig
group
pathogen
subset
amplif
recombin
chip
analysi
futur
variabl
pathogen
partit
mix
perform
conserv
pathogen
ie
bacteria
affect
primer
chang
mix
target
ad
requir
recalibr
simplifi
redesign
altern
amplif
method
provid
necessari
sensit
comprehens
coverag
also
current
investig
despit
limit
posit
result
studi
lead
us
believ
resequenc
microarray
excel
candid
next
gener
pathogen
detect
tool
provid
modern
broadspectrum
infecti
diseas
surveil
solut
critic
decis
maker
includ
healthcar
provid
patient
public
health
author
framer
biosecur
polici
